PRECIGEN INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the and
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| (Amounts in thousands) | 2024 | 2023 |
| Cash flows from operating activities | ||
| Net loss | $(106,508) | $(62,848) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 3,865 | 5,054 |
| Gain on disposals of assets, net | (2) | (68) |
| Impairment of goodwill | 1,630 | — |
| Impairment of other noncurrent assets | 32,915 | — |
| Gain on debt retirement | — | (60) |
| Loss on reclassification of cumulative foreign currency translation adjustments | 2,915 | — |
| Amortization of discounts on investments, net | (732) | (1,294) |
| Stock-based compensation expense | 6,606 | 7,626 |
| Shares issued as payment for services | 553 | 545 |
| Accretion of debt discount and amortization of deferred financing costs | — | 60 |
| Deferred income taxes | (1,706) | (126) |
| Other noncash items | — | 3 |
| Changes in operating assets and liabilities: | ||
| Receivables: | ||
| Trade | 423 | (10) |
| Other | 431 | (267) |
| Prepaid expenses | (836) | (62) |
| Other assets | 73 | 83 |
| Accounts payable | 2,337 | (1,759) |
| Accrued compensation and benefits | 1,338 | 3,620 |
| Other accrued liabilities | (1,422) | (1,550) |
| Deferred revenue | 112 | 484 |
| Lease liabilities | (60) | 80 |
| Settlement and indemnification accruals | (1,862) | (675) |
| Net cash used in operating activities | (59,930) | (51,164) |
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| (Amounts in thousands) | 2024 | 2023 |
| Cash flows from investing activities | ||
| Purchases of investments | $(74,845) | $(153,698) |
| Sales and maturities of investments | 126,994 | 137,748 |
| Purchases of property, plant and equipment | (7,556) | (491) |
| Proceeds from sale of assets | 60 | 61 |
| Net cash provided by (used in) investing activities | 44,653 | (16,380) |
| Cash flows from financing activities | ||
| Proceeds from issuance of shares, net of issuance costs | 31,833 | 72,808 |
| Payments of long-term debt and convertible notes, including cost to retire of $120 in 2023 | — | (43,219) |
| Proceeds from stock option exercises | 346 | — |
| Net cash provided by financing activities | 32,179 | 29,589 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (25) | (306) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 16,877 | (38,261) |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 7,848 | 48,596 |
| End of period | $24,725 | $10,335 |
| Supplemental disclosure of cash flow information | ||
| Cash paid during the period for interest | $7 | $1,159 |
| Cash paid during the period for income taxes | 4 | — |
| Significant noncash activities | ||
| Accrued compensation paid in equity awards | $3,039 | $3,361 |
| Purchases of property and equipment included in accounts payable and other accrued liabilities | 733 | 772 |
| Proceeds from sale of assets included in accounts receivable | — | 16 |
| Issuance costs included in accounts payable and other accrued liabilities | 951 | — |
The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2024 and December 31, 2023 as shown above:
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Cash and cash equivalents | $24,725 | $7,578 |
| Restricted cash included in other assets | — | 270 |
| Cash, cash equivalents, and restricted cash | $24,725 | $7,848 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.